These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30835619)

  • 1. Re: Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses?
    Yongbao W; Tao L; Peng Z
    J Urol; 2019 Jun; 201(6):1207-1209. PubMed ID: 30835619
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917.
    Cimen HI; Serefoglu EC; Balbay MD
    J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histopathology following Nephrectomy for Small Renal Masses?
    Jiang P; Landman J
    Eur Urol; 2021 Oct; 80(4):519. PubMed ID: 34373139
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy R. H. Thompson, S. A. Boorjian, C. M. Lohse, B. C. Leibovich, E. D. Kwon, J. C. Cheville and M. L. Blute J Urol 2008; 179: 468-473.
    Bhandari M; Siva S
    J Urol; 2008 Oct; 180(4):1568-9; author reply 1569. PubMed ID: 18718608
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified: J. R. Bhatt, M. A. Jewett, P. O. Richard, S. Kawaguchi, N. Timilshina, A. Evans, S. Alibhai and A. Finelli J Urol 2016;196:1350-1355.
    Sanders RJ; Kryvenko ON
    J Urol; 2017 May; 197(5):1358-1359. PubMed ID: 28167073
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses: C. J. Weight, B. T. Larson, A. F. Fergany, T. Gao, B. R. Lane, S. C. Campbell, J. H. Kaouk, E. A. Klein and A. C. Novick J Urol 2010; 183: 1317-1323.
    Patel N; Sullivan M; Cranston D
    J Urol; 2010 Nov; 184(5):2213-4; author reply 2214. PubMed ID: 20864134
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Patrick O. Richard, Micheal A.S. Jewett and Antonio Finelli's Letter to the Editor re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol 2016;70:403-6.
    Kutikov A; Uzzo RG; Smaldone MC; Haifler M; Bratslavsky G; Leibovich BC
    Eur Urol; 2017 Feb; 71(2):e47-e48. PubMed ID: 27436159
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort.
    Lourenco P; Bilbey N; Gong B; Bahrabadi A; Halkier B
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1892-1900. PubMed ID: 30088062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors: T. Klatte, S. F. Shariat and M. Remzi. J Urol 2014; 191: 1209-1217.
    Larcher A; Fossati N; Lazzeri M; Buffi N; Guazzoni G
    J Urol; 2014 Dec; 192(6):1887-8. PubMed ID: 25192802
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses: W. Tabayoyong, R. Abouassaly, J. E. Kiechle, E. E. Cherullo, N. J. Meropol, N. D. Shah, S. Dong, R. H. Thompson, M. C. Smaldone, H. Zhu, S. Ialacci and S. P. Kim J Urol 2015;194:1548-1553.
    Bhattar R; Yadav SS; Priyadarshi S; Tomar V
    J Urol; 2016 Sep; 196(3):960. PubMed ID: 27311408
    [No Abstract]   [Full Text] [Related]  

  • 11. Core needle biopsy clarify the histology of the small renal masses and may prevent overtreatment.
    Azawi NH; Tolouee SA; Madsen M; Berg KD; Dahl C; Fode M
    Int Urol Nephrol; 2018 Jul; 50(7):1205-1209. PubMed ID: 29846890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy: R. H. Breau, P. L. Crispen, R. E. Jimenez, C. M. Lohse, M. L. Blute and B. C. Leibovich J Urol 2010; 183: 903-908.
    Cimen HI; Canda AE; Balbay MD
    J Urol; 2010 Nov; 184(5):2212; author reply 2212-3. PubMed ID: 20864129
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Renal mass biopsy--a renaissance? B. R. Lane, M. K. Samplaski, B. R. Herts, M. Zhou, A. C. Novick and S. C. Campbell J Urol 2008; 179: 20-27.
    Park BK
    J Urol; 2009 May; 181(5):2386. PubMed ID: 19303098
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: A retrospective comparison of 2 methods of intraoperative margin evaluation during partial nephrectomy: I. S. Hagemann and J. S. Lewis, Jr. J Urol 2009; 181: 500-505.
    Hubbard R; Ducey T; Kercher K; Teigland C
    J Urol; 2009 Sep; 182(3):1231. PubMed ID: 19628232
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: the value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses: B. A. Shannon, R. J. Cohen, H. de Bruto and R. J. Davies J Urol 2008; 180: 1257-1261.
    Park BK; Kim CK
    J Urol; 2009 Apr; 181(4):1959-60; author reply 1960. PubMed ID: 19246051
    [No Abstract]   [Full Text] [Related]  

  • 16. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol. 2021;80:760-2: Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki.
    Takahashi T
    Eur Urol; 2022 Feb; 81(2):e44-e45. PubMed ID: 34887116
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma: T. V. Johnson, A. Abbasi, A. Owen-Smith, A. Young, K. Ogan, J. Pattaras, P. Nieh, F. F. Marshall and V. A. Master J Urol 2010; 183: 480-485.
    Canda AE
    J Urol; 2010 Oct; 184(4):1570-1; author reply 1571. PubMed ID: 20728182
    [No Abstract]   [Full Text] [Related]  

  • 19. [Response to the article "Partial nephrectomy by selective renal parenchymal clamping using a new clamp" by M. Khedis, L. Bellec, B. Leobon, M. Thoulouzan, P. Labarthe, J. Nohra, M. Soulie, E. Huyghe, P. Plante, Prog. Urol., 2007; 17: 41-44].
    Lefi M; Touffahi M; Zakhama W; Saad H
    Prog Urol; 2007 Sep; 17(5):1010. PubMed ID: 17969811
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Partial nephrectomy in the setting of metastatic renal cell carcinoma: K. N. Babaian, M. M. Merrill, S. Matin, P. Tamboli, N. M. Tannir, E. Jonasch, C. G. Wood and J. A. Karam J Urol 2014; 192: 36-42.
    Giri V; Jha AK; Yadav SS
    J Urol; 2015 Feb; 193(2):733; discussion 733-4. PubMed ID: 25445577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.